Orient Pharma Co Ltd

NEW
ROCO:4166 (Taiwan)  
NT$ 25.15 -1.05 (-4.01%) Jul 23
28.11
P/B:
2.39
Market Cap:
NT$ 6.11B ($ 188.99M)
Enterprise V:
NT$ 5.68B ($ 175.65M)
Volume:
571.00K
Avg Vol (2M):
450.71K
Trade In:
Volume:
571.00K
Avg Vol (2M):
450.71K

Orient Pharma Co Ltd (ROCO:4166) Dividend

Orient Pharma Co Ltd (ROCO:4166) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -9.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ROCO:4166 Dividend

Does Orient Pharma Co Ltd (ROCO:4166) pay a dividend?

Orient Pharma Co Ltd (ROCO:4166) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Orient Pharma Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Orient Pharma Co Ltd has returned capital to shareholders via buybacks at a rate of -9.1% over the past 3 years.

What are dividend-paying alternatives to Orient Pharma Co Ltd?

For dividend-paying alternatives in Orient Pharma Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.